Finance
Results: 9289-9300 of 41935

AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer

Krishna Skandakumar Joins Debevoise as Co-Chair of Private Funds Transactions Group, Along with Partner Natalia Kubik





